Clinical Trial Update: Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment [Phase 4]

View source ↗

Summary

The update details a Phase 4 study evaluating adding entecavir to ongoing peginterferon alfa-2a in HBeAg-positive, HBV DNA-positive chronic hepatitis B patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: Beijing Ditan Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN